Diversey's Oxivir 1 gets C. Auris claim for Oxivir 1

In a recent press release, Diversey announced that the Environmental Protection Agency (EPA) has approved the addition of Candida auris (C. auris) to the master label of Oxivir® 1, in both its ready-to-use and wipes formats.

Oxivir 1 is effective against C. auris and a broad spectrum of pathogens in just 1 minute.

 Oxivir 1 is the first non-bleach disinfectant specifically approved as effective against C. auris by the EPA. The EPA recognizes that C. auris is a serious public health threat, particularly in healthcare settings, and until now, there have been no EPA-approved products specifically registered to control C. auris. Oxivir 1 products have now been tested and passed EPA’s review to secure registration of this emerging, and difficult-to-kill pathogen. This applies to both RTU and Wipes, EPA registration Nos. 70627-74 and 70627-77, respectively.

Click here to continue>>

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 


Patient Safety Tools & Resources Database

Top 40 Articles from the Past 6 Months